arrow
Y

Young Nyun Park

Yonsei University College of Medicine
H指数:76
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A refined MASH–HCC model identifies macrophage Gadd45b as a key orchestrator of inflammation-driven neoplastic progression

改进的MASH–HCC模型确定巨噬细胞Gadd45b为炎症驱动性癌变进展的关键调控因子

2026-09-160
OA
Analytical validation of short-read genome sequencing for diagnostic panel and exome testing

短读基因组测序在诊断面板和外显子检测中的分析验证

2026-05-280
PRE
Consensus position statements for the standardized application of histological grading and staging systems in MASH clinical trials

关于MASH临床试验中组织学分级和分期系统标准化应用的一致性立场声明

2025-10-080
PRE
Vessels That Encapsulate Tumor Cluster plus Unresectable Hepatocellular Carcinomas Benefit of Antiangiogenic Therapy

包裹肿瘤簇且无法切除的肝细胞癌血管的抗血管生成治疗获益

2025-09-010
OA
The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment

《柳叶刀》关于应对全球肝细胞癌负担的委员会报告:从预防到治疗的综合策略

2025-07-280
PRE
Cannabidiol potentiates p53-driven autophagic cell death in non-small cell lung cancer following DNA damage: a novel synergistic approach beyond canonical pathways

Cannabidiol通过DNA损伤后增强p53驱动的自噬性细胞死亡,在非小细胞肺癌中展现出一种超越经典通路的新型协同策略。

2025-05-010
OA
Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial (vol 30, pg 807, 2024)

基因组生物标志物预测阿替利珠单抗联合贝伐珠单抗免疫治疗在肝细胞癌中的疗效:来自IMbrave150试验的见解(卷30,页807,2024)

2025-02-270
OA
Severe acute liver disease in adults: Contemporary role of histopathology
2024-05-213
OA